Patient-reported outcomes in breast cancer FDA drug labels and review documents

BACKGROUND: Patient-reported outcomes (PROs) can provide valuable information about drug benefit-risk tradeoffs from the patient perspective and are particularly important to patients with breast cancer due to its symptoms and adverse events from breast cancer treatments. The United States Food and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Kyungwan, Majercak, Kayleigh R., Villalonga-Olives, Ester, Perfetto, Eleanor M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060367/
https://www.ncbi.nlm.nih.gov/pubmed/33881661
http://dx.doi.org/10.1186/s41687-021-00308-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060367/
https://www.ncbi.nlm.nih.gov/pubmed/33881661
http://dx.doi.org/10.1186/s41687-021-00308-y

Ejemplares similares